Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | STAT3 | P40763 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6238329 | 0.95 | STAT3 (0.47) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL9458218 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL8863706 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL30850377 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL17614843 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL25030574 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL8864017 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL7827739 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL9764712 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A | |
| SCHEMBL10449020 | 0.94 | STAT3 (0.46) | TSHRSTAT3L3MBTL1PSMD10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219932-A1 | COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME | FUJIFILM CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| EP-0222413-B1 | NOVEL FORSKOLIN DERIVATIVES | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-02-05 | — | — | EP | disclosed |
| US-4954642-A | INOTROPIC, HYPOTENSIVE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1990-09-04 | — | — | US | disclosed |
| EP-0222413-A2 | Novel forskolin derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219932-A1 | COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME | BMP1, BMP2, NPSR1 | TSHR 685/4885STAT3 2111/4885L3MBTL1 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.